Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway

doi:10.4251/wjgo.v13.i9.1164

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6193)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

386

WORD

200

HTML

3500

Figures (1-5)

337

Sum=4423

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

521

Download

1248

Sum=1769

Sep 15, 2021 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1164-1183
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1164

Full Size Figure Download Figure

Figure 1 Target genes of scoparone in pancreatic cancer obtained by network bioinformatics analyses. A: The two-dimensional structure of scoparone; B: A total of 83 overlapping therapeutic pancreatic cancer targets of scoparone; C: GO analysis of 83 predicted pancreatic cancer targets of scoparone through the WebGastalt database; D: KEGG analysis of 83 predicted pancreatic cancer targets of scoparone through the WebGastalt database; E: Overlapping targets in four enriched pathways identified by KEGG analysis.

Citation: Li N, Yang F, Liu DY, Guo JT, Ge N, Sun SY. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. World J Gastrointest Oncol 2021; 13(9): 1164-1183
URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1164.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1164